Metabolism studies of 4′Cl‐CUMYL‐PINACA, 4′F‐CUMYL‐5F‐PINACA and 4′F‐CUMYL‐5F‐PICA using human hepatocytes and LC‐QTOF‐MS analysis. Issue 3 (3rd January 2023)
- Record Type:
- Journal Article
- Title:
- Metabolism studies of 4′Cl‐CUMYL‐PINACA, 4′F‐CUMYL‐5F‐PINACA and 4′F‐CUMYL‐5F‐PICA using human hepatocytes and LC‐QTOF‐MS analysis. Issue 3 (3rd January 2023)
- Main Title:
- Metabolism studies of 4′Cl‐CUMYL‐PINACA, 4′F‐CUMYL‐5F‐PINACA and 4′F‐CUMYL‐5F‐PICA using human hepatocytes and LC‐QTOF‐MS analysis
- Authors:
- Stalberga, Darta
Ingvarsson, Sarah
Bessa, Ghidaa
Maas, Lisa
Vikingsson, Svante
Persson, Mattias
Norman, Caitlyn
Gréen, Henrik - Abstract:
- Abstract: 4′Cl‐cumyl‐PINACA (SGT‐157), 4′F‐cumyl‐5F‐PINACA (4F‐cumyl‐5F‐PINACA, SGT‐65) and 4′F‐cumyl‐5F‐PICA (4F‐cumyl‐5F‐PICA, SGT‐64) are a series of new halogenated cumyl synthetic cannabinoid receptor agonists (SCRAs). Due to rapid metabolism, monitoring and screening for SCRAs in biological matrices requires identification of their metabolites. It is an essential tool for estimating their spread and fluctuations in the global illicit market. The purpose of this study was to identify human biotransformations of 4′Cl‐cumyl‐PINACA, 4′F‐cumyl‐5F‐PINACA and 4′F‐cumyl‐5F‐PICA in vitro and characterize for the first time the metabolic pathways of halogenated cumyl SCRAs. 4′Cl‐cumyl‐PINACA, 4′F‐cumyl‐5F‐PINACA and 4′F‐cumyl‐5F‐PICA were incubated with human hepatocytes in duplicates for 0, 1, 3 and 5 h. The supernatants were analysed in data‐dependent acquisition on a UHPLC‐QToF‐MS, and the potential metabolites were tentatively identified. A total of 11 metabolites were detected for 4′Cl‐cumyl‐PINACA, 21 for 4′F‐cumyl‐5F‐PINACA and 10 for 4′F‐cumyl‐5F‐PICA. The main biotransformations were oxidative defluorination, followed by hydroxylation with dehydrogenation, N‐dealkylation, dihydrodiol formation and glucuronidation. Hydroxylations were most common at the tail moieties with higher abundancy for indole than indazole compounds. N‐dealkylations were more common for fluorinated tail chain compounds than the non‐fluorinated 4′Cl‐cumyl‐PINACA. In conclusion, many metabolitesAbstract: 4′Cl‐cumyl‐PINACA (SGT‐157), 4′F‐cumyl‐5F‐PINACA (4F‐cumyl‐5F‐PINACA, SGT‐65) and 4′F‐cumyl‐5F‐PICA (4F‐cumyl‐5F‐PICA, SGT‐64) are a series of new halogenated cumyl synthetic cannabinoid receptor agonists (SCRAs). Due to rapid metabolism, monitoring and screening for SCRAs in biological matrices requires identification of their metabolites. It is an essential tool for estimating their spread and fluctuations in the global illicit market. The purpose of this study was to identify human biotransformations of 4′Cl‐cumyl‐PINACA, 4′F‐cumyl‐5F‐PINACA and 4′F‐cumyl‐5F‐PICA in vitro and characterize for the first time the metabolic pathways of halogenated cumyl SCRAs. 4′Cl‐cumyl‐PINACA, 4′F‐cumyl‐5F‐PINACA and 4′F‐cumyl‐5F‐PICA were incubated with human hepatocytes in duplicates for 0, 1, 3 and 5 h. The supernatants were analysed in data‐dependent acquisition on a UHPLC‐QToF‐MS, and the potential metabolites were tentatively identified. A total of 11 metabolites were detected for 4′Cl‐cumyl‐PINACA, 21 for 4′F‐cumyl‐5F‐PINACA and 10 for 4′F‐cumyl‐5F‐PICA. The main biotransformations were oxidative defluorination, followed by hydroxylation with dehydrogenation, N‐dealkylation, dihydrodiol formation and glucuronidation. Hydroxylations were most common at the tail moieties with higher abundancy for indole than indazole compounds. N‐dealkylations were more common for fluorinated tail chain compounds than the non‐fluorinated 4′Cl‐cumyl‐PINACA. In conclusion, many metabolites retained halogen groups at the cumyl moieties which, in various combinations, may be suitable as analytical biomarkers. … (more)
- Is Part Of:
- Basic & clinical pharmacology & toxicology. Volume 132:Issue 3(2023)
- Journal:
- Basic & clinical pharmacology & toxicology
- Issue:
- Volume 132:Issue 3(2023)
- Issue Display:
- Volume 132, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 132
- Issue:
- 3
- Issue Sort Value:
- 2023-0132-0003-0000
- Page Start:
- 263
- Page End:
- 280
- Publication Date:
- 2023-01-03
- Subjects:
- human hepatocytes -- metabolism -- metabolites -- new psychoactive substances -- synthetic cannabinoids
Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology, Clinical -- Periodicals
Computer network resources
Electronic journals
615.1 - Journal URLs:
- http://firstsearch.oclc.org/journal=1742-7835;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-7843 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=pto ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcpt.13829 ↗
- Languages:
- English
- ISSNs:
- 1742-7835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1863.914250
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25708.xml